Dialogue Webinar [Held on 12/1 (Thursday)] Announcement of the "CELL & GENE THERAPY" Webinar (Sponsored) [Participation Fee: Free]

Small sample (100µL), high-throughput automatic cell counter using trypan blue dye exclusion method.

A cell counter capable of high throughput with over 45 measurements per hour - Can measure small samples (100μL) - High throughput rapid measurement of approximately 45 measurements per hour - Wide measurement range: 0.5×1,000,000 to 1.4×100,000,000 cells/mL - Automatic analysis without external dilution due to internal dilution function - Continuous sampling from 32-position dedicated sample cups or 96 deep well plates - Compliant with 21 CFR Part 11 - Supports network transfer of data and images - Easy maintenance with packaged reagents

• Other physicochemical equipment

A fully automated cell density/survival rate analyzer that processes over 45 samples of 100μL each at high speed in one hour. No manual dilution is required for high-density cultured cells.

The fully automated cell density/survival rate analyzer "BioProfile FAST CDV" requires only 100μL of sample for cell counting. With continuous processing through a dual flow path, it achieves a high throughput of over 45 measurements per hour. It can automatically measure high-density cells up to 1.4×10^8 cells/mL without manual dilution. The measurement and maintenance processes are thoroughly simplified with automatic handling of dilution, staining, and viability assessment, as well as large-capacity, pack-style reagents. 【Features】 - Required sample: 100µL - Rapid measurement: over 45 measurements per hour high throughput - Various sampling methods including 32-position trays and 96-well plates - Measurement range of 0.5×10^5 - 1.4×10^8 cells/mL without manual dilution - Continuous measurement of up to 500 samples with large-capacity reagent packs - Automatic flow path flushing to prevent clogging - Compliant with 21 CFR Part 11; can be utilized for GMP compliance - Capable of network transfer of data and images *For detailed specifications, please download from below. Feel free to inquire about product descriptions, demos, and quotes. Inquiries about FLEX2 (automated analysis system for cell culture environments) are also welcome.

• Particle Counter

Managing cultivation environments from basic research to commercial manufacturing in a one-stop solution. Auto-sampling is also possible. Proven track record with major pharmaceutical companies both domestically and internationally.

The "BioProfile FLEX2" is an automatic analysis device that can measure up to 16 items, including major metabolites and gas components in cell culture media, osmotic pressure of the culture medium, and cell proliferation, in approximately 4.5 minutes. It can measure multiple items at once, and the required sample volume is as low as 245μL. The sensor card, which allows for easy replacement of consumables, and the pack-style design reduce maintenance time. An online function also enables auto-sampling from bioreactors (optional). It is suitable for managing the manufacturing processes of cell processing products and antibody pharmaceuticals, exploring optimal culture conditions for cell culture, and collecting fundamental data to ensure reproducibility and reliability in cell-based research. It also supports data integrity and compliance with GMP validation. 【Features】 ■ No need for measurements with multiple machines, reducing labor hours ■ Non-invasive measurements are possible ■ Auto-sampling for up to several weeks is possible (in collaboration with other systems) ■ Automatic quality control functions within the device ensure verification of true performance values ■ Extensive support services (installation, repairs, technical support via phone and email, etc.) *For more details, please refer to the PDF document or feel free to contact us.

• Other environmental analysis equipment

Presentation of Cell Culture Medium Analysis Explanation Materials: An analytical device capable of simultaneous measurement and analysis of up to 16 items in 4 minutes and 30 seconds! For creating appropriate culture environments and improving efficiency in compliance with GMP.

The "BioProfile FLEX2" is an automated analysis device for cell culture environments that can simultaneously analyze up to 16 components of cell culture media. In just 4.5 minutes, it quantifies culture conditions such as metabolism, proliferation, and differentiation, contributing to the efficiency of "continuity assessment of the cell manufacturing process," "creating a culture environment with an eye on mass production," and "quality control and documentation of standards in line with GMP compliance." It is equipped with sample containers of various shapes, requiring a small sample volume of 135 to 265 μL. For chemical substances and gas measurements, it uses sensor cards that do not require electrode maintenance. 【Features】 ■ Capable of simultaneous analysis of up to 16 items ■ Rapid measurement time: as short as 2 minutes and as long as 4 minutes and 30 seconds (depending on the measurement item) ■ Can measure the consumption and production rates of major metabolites 【Exhibition Information】 Name: BioJapan 2024 Venue: Pacifico Yokohama D-39 Date: October 9-11, 2024 Featured Products: Demonstration of "BioProfile FLEX2" and "BioProfile FAST CDV" media analysis! A 70% off campaign for "Stat Profile Prime" is currently underway! (Until the end of December) *Analysis explanation materials are currently available! Please check from "PDF Download."

• Other physicochemical equipment

Nova Biomedical offers webinars that can be viewed online at any time.

□■ Latest Webinar Title □■ ------------------------------------------------------------------------------------- Possibilities of Measuring Medium Components in Cell Manufacturing Speaker: Masahiro Kinooka, Ph.D. (Professor, Osaka University Graduate School) ------------------------------------------------------------------------------------- In applying to process management for cell manufacturing that contributes to regenerative medicine, methods that do not affect production are required. The opportunities for cell measurement technologies are limited, and environmental measurements are also necessary. In this webinar, we will focus on medium component measurement technology within environmental measurements and introduce the possibilities of medium measurement for understanding cell and culture conditions based on our experience in measuring medium components.

• Other Culture
• Seminar
• Other analytical and testing equipment

Accelerating the development of the COVID-19 vaccine - Rapid simultaneous measurement of multiple items with trace samples using the automatic analysis device for cell culture environments, FLEX2.

To prevent the spread of the novel coronavirus (COVID-19), the urgent development of vaccines is required. It is said that managing the culture environment is crucial in the process of vaccine research and development involving host cell cultures. The "BioProfile" series of cell culture environment analysis devices from Nova Biomedical is widely adopted by major pharmaceutical companies and institutions in Japan and around the world for managing culture environments in vaccine research, development, and manufacturing processes. At Nova Biomedical, we hope to contribute, albeit modestly, to the development of COVID-19 vaccines by offering flexible purchasing programs tailored to your budget. For more details, please contact us through the inquiry form, and we will respond promptly. We also have materials available for cell culture analysis using our devices. 【Features】 - Monitoring the progress of cell culture - Quantification of key components in the culture medium - Early detection of abnormalities in the culture environment through regular monitoring - Capability to measure multiple items with one device, significantly reducing measurement time by consolidating the functions of multiple devices into one - Numerical backing for the timing of medium changes - Maintenance-free and sensor card-based, reducing the workload for researchers on equipment maintenance

• Other physicochemical equipment

We will be exhibiting from Wednesday, October 1 to Friday, October 3, 2025. Makuhari Messe https://www.jagri-global.jp/hub/ja-jp/visit/feature-t/plant.html Please stop by!

To construction and civil engineering companies looking for the "next" step in digitalization. This seminar will explain the currently trending topic of "AI utilization" in 45 minutes. We will clearly introduce the latest trends, specific case studies, and steps for implementation to address questions such as "What can AI do?" and "How can it be applied to our business?" Whether your company is already advancing in DX or is just starting to consider AI, you will find hints for improving operational efficiency. 【Schedule】 1: Company introduction and instructor introduction 2: Case studies of AI utilization in the construction and civil engineering industry 3: Convincing examples! Patterns of AI utilization in construction operations 4: Three steps to avoid failure in AI implementation 5: Q&A and closing remarks

We will address the issue of young employees who, despite joining the company, leave due to reasons such as "there's no time to be taught," "I don't understand when I'm told to learn by watching," and "what is written and said varies depending on the project or person in charge." We propose a system that accumulates the know-how of veterans in AI and systems, allowing young employees to search for and solve problems on their own. 【Schedule】 1: Company introduction and instructor introduction 2: Reasons why technical inheritance is not progressing (lack of time, difficulty in verbalizing) 3: "Next-generation manual and know-how sharing methods" utilizing video and AI search 4: Examples of system construction to institutionalize technical inheritance 5: Q&A and closing remarks

[Speaker] Kentarou Kobe, Senior Consultant Mitsubishi Research Institute, Inc. Power and Energy Division Demand Side Innovation Group [Key Lecture Content] As we strive for carbon neutrality, the importance of stationary storage batteries that support the expansion of renewable energy adoption and the stabilization of electricity supply and demand is increasing. On the other hand, the environment surrounding the battery storage business is undergoing significant changes, including the review of electricity markets and systems, increased renewable energy output control, expanded utilization of demand-side resources, grid connection, cell procurement, cybersecurity, and regional coexistence. In this lecture, we will organize the values required for future battery storage businesses from four perspectives: power system value, renewable energy value, consumer value, and regional value. Based on this, we will introduce points for consideration in business development, focusing on grid-connected and renewable energy co-located systems, taking into account the characteristics of each type. [Lecture Items] 1. Current status of the domestic battery storage market and the future image of battery storage required 2. Market and system trends surrounding grid-connected battery storage and key points 3. Market and system trends surrounding renewable energy co-located battery storage and key points 4. Points for consideration in battery storage businesses that provide multiple values 5. Summary 6. Q&A / Business card exchange

[Lecturers] Accenture Ltd. Industry & Enterprise Headquarters Managing Director Yuya Horiguchi, Head of Telecommunications and Media Practice Japan Senior Manager Mamoru Yonemura, Digital Core Strategy [Key Lecture Content] This presentation will analyze the next structure of the telecommunications industry from the perspective of investment and business strategy regarding 6G. As standardization intensifies in preparation for commercialization around 2030, there is also strong caution that we may "repeat the same mistakes as with 5G." Starting from environmental changes that could not be anticipated in 2020, such as the expansion of generative AI demand, commercialization of NTN (satellite communications), data sovereignty, and power/supply constraints, we will organize the points of discussion on infrastructure investment, business restructuring, sharing, and monetization. From the standpoint of connecting enterprise demand with telecommunications infrastructure, we will present the investment decisions that telecommunications operators should make and the materials for their next steps.